Company intelligence
Seuss+
Helping Sponsors Overcome Vendor Challenges in Clinical Development
About Seuss+
Seuss+ specializes in optimizing vendor relationships for biotech and pharmaceutical companies, ensuring clinical trials run efficiently, on time, and within budget. Founded in 2012, we bring over a decade of experience in strategic vendor management, helping sponsors select, manage, and collaborate with the right partners to achieve clinical success. Our proactive approach aims to prevent issues before they arise, accelerating the delivery of life-saving therapies to patients. We offer tailored strategies that align with both operational goals and trial outcomes. Discover More: https://www.seuss.plus
Verified activity
Signals from Seuss+
3 published signals
People
Seuss+ CEO and Co-Founder Kieran Engels will join Ross Pettit, Chief Development Officer at Kestrel Therapeutics, and Limor Ben Har, Chief Operating Officer at Prilenia at LSX Congress USA 2026 for the Biotech CEO Forum.
Reported by Seuss+
Products & Services
Seuss+ launched the Ripple Talk podcast live on its website.
Reported by Sabine Hutchison
People
Seuss+ opened applications for the next cohort of mentors and parents.
Reported by Sabine Hutchison